Research on Dural Arteriovenous Fistulas at Xuanwu Hospital
Dural Arteriovenous Fistulas Research at China INI
This study is collecting information from adults with dural arteriovenous fistulas to better understand the condition and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1180 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Xuanwu Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06543472 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on collecting clinical data from adult patients diagnosed with dural arteriovenous fistulas (DAVFs) at Xuanwu Hospital. The aim is to create a comprehensive database and biobank to better understand the pathogenesis, vascular architecture, biological markers, and treatment outcomes associated with DAVFs. By addressing current controversies and unresolved issues in the treatment of DAVFs, the study seeks to provide insights into optimal treatment strategies and prognosis, particularly for specific types of DAVFs. The research is motivated by the increasing incidence of DAVFs and the need for large-sample studies to clarify existing knowledge gaps.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients diagnosed with dural arteriovenous fistulas who are admitted to Xuanwu Hospital.
Not a fit: Patients with non-DAVF lesions confirmed by DSA will not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for patients with dural arteriovenous fistulas.
How similar studies have performed: While there have been large-scale retrospective studies on DAVFs, this study is novel in its focus on a single-center approach to gather comprehensive data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with DAVFs who were admitted to Xuanwu Hospital. Exclusion Criteria: * Non-DAVF lesions confirmed by DSA.
Where this trial is running
Beijing
- Xuanwu Hospital, Capital Medical University — Beijing, China (Recruiting)
Study contacts
- Principal investigator: Xin Su, MD — Xuanwu Hospital Department of Neurosurgery
- Study coordinator: Peng Zhang, MD
- Email: zhangpengwr@126.com
- Phone: 010-83198899
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.